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Abstract.  A variant of the ACTH-secreting pituitary 
cell line, AtT-20, has been isolated that does not make 
ACTH, sulfated proteins characteristic of the regulated 
secretory pathway, or dense-core secretory granules 
but retains constitutive secretion. Unlike wild type 
AtT-20 cells, the variant cannot store or release on 
stimulation, free glycosaminoglycan (GAG) chains. In 
addition, the variant cells cannot store trypsinogen or 
proinsulin, proteins that are targeted to dense core 
secretory granules in wild type cells. The regulated 
pathway could not be restored by transfecting with 
DNA encoding trypsinogen, a soluble regulated secre- 
tory protein targeted to secretory granules. A compar- 
ison of secretion from variant and wild type cells al- 
lows a distinction to be made between constitutive 
secretion and basal secretion, the spontaneous release 
of regulated proteins that occurs in the absence of 
stimulation. 
I 
s cells that have specialized regulated secretory vesicles, 
called secretory granules,  sorting of the regulated se- 
cretory  products  away from  constitutively  secreted 
products and from lysosomal enzymes occurs in the trans- 
Golgi network  (Griffiths and Simons,  1986; Tooze et al., 
1987; Orci et al.,  1987). The concentrated contents of the 
secretory granules are released from cells in response to ex- 
ternal signals, whereas no signals are required for constitu- 
tive secretion.  The mechanism of protein  sorting between 
these two secretory pathways is not known; both a hormone- 
specific receptor mechanism (Chung et al., 1989) and selec- 
tive condensation of  secretory granule contents (Kelly, 1985; 
Gerdes et al., 1989) have been proposed. 
Analysis of the  secretory  process  is made easier  when 
secretion-defective mutants are available. The steps involved 
in constitutive secretion have been elucidated in yeast using 
temperature-sensitive  secretion  mutants  (Novick  et  al., 
1980; Schekman,  1985). In mammalian cells, mutants have 
been described  that influence secretion,  but most of these 
mutations involve changes in the structure of the secretory 
protein itself, or changes in its posttranslational modification 
(for review see Tartakoff, 1983). Many examples of  defective 
secretion  involve proteins  that are  constitutively secreted, 
such as immunoglobulin chains (for review see Scharff et al., 
1975) or viral glycoproteins (Tufaro et al., 1987). Mutations 
in the machinery  of constitutive secretion  are often lethal 
since the constitutive pathway is responsible for the normal 
membrane traffic vital for cell growth. Nonlethal mutations 
that affect the regulated secretory process have been reported 
for  ciliated  protozoa,  for  example  in  the  exocytosis  of 
trichocysts in Paramecium (Aufderheide, 1978; Lefort-Tran 
et al.,  1981) and mucocysts in Tetrahymena (Orias  et al., 
1983; Maihle and Satir,  1985). In this paper we describe 
a mammalian cell variant that has lost its capacity for regu- 
lated secretion. 
The mouse pituitary cell line, AtT-20, expresses the hor- 
mone, ACTH, and packages it in electron-dense  secretory 
granules (Mains and Eipper, 1976). In addition to regulated 
secretion of ACTH,  AtT-20 cells  secrete proteins  such as 
laminin from a constitutive secretory pathway (Burgess et 
al., 1985). In this paper we have characterized a variant of 
AtT-20 cells that does not express several soluble markers of 
the dense core secretory vesicle, including ACTH, and does 
not have morphologically identifiable dense core secretory 
granules. We are now able to experimentally distinguish in 
endocrine cells, two types of unstimulated secretion,  basal 
release and constitutive secretion. In earlier estimates of the 
efficiency of sorting in AtT-20 cells we ignored basal secre- 
tion  when measuring  sorting  into the  regulated  pathway 
(Moore and Kelly, 1985). The secretion properties  of the 
variant  cell  line  indicated  that  a  considerable  fraction  of 
the protein sorted into the regulated pathway was secreted in 
the absence of stimulation by what we term basal secretion. 
Materials and Methods 
Materials 
Synthetic DNA linkers, restriction endonucleases, and polynucleotide ki- 
nase were from New England Biolabs (Beverly,  MA). DNA polymerase I 
(Klenow) and T4 DNA Ligase were from Boehringer Mannheim Biochemi- 
cals  (Indianapolis,  IN).  [35Slmethionine,  [35S]cysteine,  and  [35S]sulfate 
were from Amersham Corp. (Arlington Heights, IL). Trans-[35S]label  was 
from ICN Radiochemicals (Irvine, CA). t25I-ACTH, used as a tracer in the 
ACTH RIA was obtained from the Metabolic Research Lab at The Univer- 
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antibodies used for immunofluorescence  and RIA were described previ- 
ously (Moore et al., 1983b). Rabbit  anti-mouse ~ chain antiserum and rabbit 
anti-guinea  pig IgG were from ICN Biomedicals, Inc. (Irvine, CA). Guinea 
pig anti-porcine or anti-human insulin and rabbit anti-human insulin C 
pepfide were obtained from Linco Inc. (St. Louis, MO). Rabbit anti-tryp- 
sinogen was obtained from Dr. Charles Craik (University  of California, San 
Francisco, CA). Rabbit anti-sheep IgG was from Organun Teknika-Cappel 
(Malvern, PA). Rabbit anti-rat synaptic vesicle antiserum that recognized 
synaptophysin  (p38) was prepared by Dr.  Dan Cutler and Dr.  Peg Kelly 
(Cutler and Cramer,  1990).  Mouse monoclonal anti-synaptophysin was 
from Boehringer Mannheim  Biochemicals.  Protein A-bearing Staphylococ- 
cus aureus, Cowan strain bacterial cells (SAC) l (Pansorbin or Zysorbin) 
were  from Calbiochem-Behring Corp.,  American Hoechst Corp.  (San 
Diego,  CA) or Zymed Labs (San Francisco,  CA). 8-bromo-(8-Br)  cAMP, 
ouabain, and 4-methyl umbelliferyl/3-v-xyloside were from Sigma Chemi- 
cal Co.  (St.  Louis,  MO). 
Cell Culture 
The MPC-11 myeloma derivative,  4TOO1 (Margulies et al.,  1976), resis- 
tant to 2.5 mM ouabain and 5 ttg/mi 6-thioguanine but sensitive to HAT 
medium (100 ttM hypoxanthine, 30/tM thymidine, and 10 ~M aminopterin) 
was originally derived by Dr. Matthew D. Scbatff (Albert Einstein College 
of Medicine,  Bronx,  NY)  and obtained from  Dr.  Sherie L.  Morrison 
(University of California, Los Angeles, CA). Cells were grown at 37°C in 
DME H21, (4.5 g glucose/liter) supplemented with 10% FCS (HyClone 
Laboratories,  Logan,  UT),  penicillin/streptomycin, and kept in an at- 
mosphere of 5% CO2. Afr-20 F2 cells were as described (Mains and Eip- 
per,  1976;  Gumbiner and Kelly,  1982).  AtT20/D16V-WT#6 cells (Sabol, 
1980) were from Laurel Thomas (Oregon Health Sciences University, Port- 
land, OR). ART-20 cells were grown at 37°C in DME H21 containing 10% 
FCS,  penicillin/streptomycin, and kept in an atmosphere of 15% (for F2 
cells) or 10% (for WT#6 cells) CO2. 
Construction of  Expression Vectors 
The pRSV trypsinogen expression vector was as described previously (Bur- 
gess et al., 1987). Other expression vectors containing genomic clones car- 
rying  their endogenous polyadenylation  signals  were  constructed  in  a 
derivative  of  an  RSV-LTR  plasmid  containing  the  chloramphenicol 
acetyltransferase (CAT) gene (Gorman et al.,  1982). In these vectors, the 
CAT gene was removed and replaced  with either a Barn HI or a Hind III 
site, using DNA linkers, pBR322-MPC-11  K  (Kelley et al.,  1982), contain- 
ing an 8.5-kb Barn HI fragment with the entire rearranged mouse Ig ~ chain 
genomic clone from the MPC-11 myeloma (Laskov and Scharff,  1970), was 
obtained from Dr. Brain Van Ness (University of Iowa, Iowa City, IO). The 
8.5-kb K  chain genomic clone was cleaved with Pvu II, which removed un- 
wanted 5' sequences and brought the start site of the kappa chain gene within 
30 bp of the 5' end of the DNA fragment. This truncated Pvu II-Bam HI 
fragment was adapted with Barn HI linkers and cloned into an RSV-LTR- 
containing expression vector at the Barn HI site. pBR322-human proinsu- 
lin,  pInsC2  (Laub and Rntter,  1983),  was  obtained from Dr.  Michael 
Walker and Dr. William J. Rutter (University of California, San Francisco, 
CA). The proinsulin gene contained in this plasmid is a chimera between 
a eDNA at the 5' end and 3' genomic sequences carrying endogenous poly- 
adenylation signals.  The proinsulin gene on a 1.2-kb Eco RI fragment was 
removed from pIasC2 and cloned into an RSV-containing expression vector 
using Hind HI linkers.  All large scale plasmid preps were isolated  from 
HBI01 bacterial cells by the cleared lysate technique (Clewell and Helinski, 
1972)  and plasmids were purified through two equilibrium gradients of 
cesium chloride using standard procedures (Maniatis et al.,  1982). 
DNA Transfections 
DNA transfections of AtT-20 cells was by a calcium phosphate precipitation 
protocol (Moore et al.,  1983b).  For stable transformation, 100 ttg (for 
AtT-20 F2) or 50/tg (for ART-20 WT#6) of various plasmid DNAs and 20 
t~g of a  selectable DNA pSV2-neo  (Southern and Berg,  1982),  or pTK- 
hygromycin resistance plasmid (pHS-53; from Dr. Dan Littman, University 
of California, San Francisco,  CA),  were mixed and applied as a calcium 
1. Abbreviations used in this paper: CAT, chioramphenicol acetyltransfer- 
ase; 8-Br, 8-bromide; GAG, glycosaminoglycan;  PEG, polyethylene glycol; 
SAC, Cowan strain bacterial cells. 
phosphate precipitate to  10-cm dishes (",,3  ×  105 cells/dish) of ART-20 
cells. Stable clones were selected in either 0.25 mg/ml (for F2) or 0.5 mg/mi 
(for WT#6) of the antibiotic G418 (Geneticin; Gibco Laboratories, Grand 
Island, NY) or with 0.175 mg/ml hygromycin (Boehringer Mannheim Bio- 
chemicals).  Drug-resistant clones were  screened for production of the 
desired protein by metabolic labeling followed by immunoprecipitation of 
cell extracts  and culture media with the appropriate antibodies and fixed 
protein A-containing bacterial cells.  Immunoprecipitates were analyzed 
with SDS-PAGE followed by autoradiography.  Transfected wild type ART-20 
F2 cells expressing  trypsinogen are as described (Burgess  et al.,  1987). 
ART-20 WT#6 ceils expressing proinsulin were generated by Dr. Sam Green 
(University of California, San Francisco,  CA) using the human proinsu- 
lin-containing expression vector described above. 
Isolation of Variants 
Variants of ART-20 cells,  HYA.15.6 and HYA.15.10, were isolated as slow 
growing clones that survived several rounds of drug selection during a so- 
matic cell hybridization procedure (Kohler and Milstein, 1976; Margulies 
et al., 1976) between ART-20 F2 ceils (HAT resistant, ouabain sensitive) and 
the mouse myeloma, 4TOO1 (HAT sensitive, ouabain resistant). Equal num- 
bers of both cell types were mixed in suspension centrifuged at low speed 
(2,000 g) to form a pellet.  The cells were resuspended in serum-free DME 
containing 35% polyethylene  glycol 4,000 (PEG), pH 8.2,  incubated for 
90 s and then immediately diluted with 40 mi of fresh medium. Cells were 
removed from the PEG by low-speed centrifugation and then resuspended 
in DME containing 10% FCS,  HAT, and 2.5 mM oubain. The selection 
medium was changed every 48 h until >99 % of the cells were killed. Slower 
growing clones exhibiting the qualities described in the results were recov- 
ered and subcloned additional  times to ensure their homogeneity. 
Metabolic Labeling and Immunoprecipitation 
Sulfated proteins were labeled by incubating cells for 18 h at normal growth 
conditions of 37°C and 10-15%  CO2, in sulfate-depleted  DME H21 con- 
raining 5 mCi [35S]sulfate, penicillin, streptomycin,  glutamine, and 10% 
dialyzed FCS as described (Moore et al., 1983a). Cells were then incubated 
in serum-free DME H21 for two 1.5-h intervals,  the latter interval in the 
presence or absence of 5 mM 8-Br-cAMP. Samples were precipitated with 
cold 10% TCA containing 1 mg/ml deoxycholate,  washed twice with cold 
acetone, and redissolved  in SDS-PAGE sample buffer. Analysis was per- 
formed on 12-20% polyacrylamide  gradient gels,  which were soaked  in 
0.5 M sodium salicylate containing 30% methanol, dried, and exposed to 
film (XAR-5;  Eastman Kodak Co., Rochester,  NY). 
Sulfated,  free GAG chains were generated as described (Burgess  and 
Kelly,  1984)  by preincubating cells for 2.5-3  h  in DME  H21  growth 
medium containing 0.5 mM 4-methylumbelliferyl  ~-v-xyloside and then in- 
cubating the cells in sulfate-depleted  DME H21  containing xyloside  and 
-35  5 rnCi [  S]sulfate. Cells were chased by incubating for 2.5 h in serum-free 
medium containing xyloside. The medium was collected, and then analyzed 
directly on 12-20% polyacrylamide  gels that were processed for autoradi- 
ography as described above. Pulse-chase experiments  to follow free GAG 
chains were performed by preparing confluent six-well dishes (12 wells), 
preincobating for 1 h in DME containing 0.5 mM xyloside,  shortening the 
labeling time in 5 mCi [35S]sulfate to 1 h, washing the cells with PBS, and 
incubating for 15, 30, 45, 60, 90, 120, 150, or 210 rain in complete growth 
medium. At 60 min of chase, 5 mM 8-Br-cAMP was added to one well of 
ceils and the media collected at 150 rain. At 150 rain of cbase, cAMP was 
added to a second and the media collected  at 210 rain. At the end of the 
chase intervals,  media were removed from the cells,  dialyzed  for 24 h at 
4°C against three changes of 50 mM NI-LtHCO3, dried in a Speed Vac (Sa- 
vant Instruments, Hicksviile,  NY) for 6 h, dissolved in SDS-PAGE sample 
buffer,  and then analyzed on  12-20%  polyacrylamide  gels as described 
above.  Cell extracts  were prepared by direct lysis in NDET buffer  (1% 
NP-40, 0.4% deoxycholate,  66 mM EDTA,  10 mM Tris, pH 7.4; Burgess 
et al.,  1985), removing the nuclei, adding SDS-PAGE sample buffer, and 
loading portions directly on polyacrylamide gels. GAG chains were quan- 
tiffed by cutting out the parts of  the gels containing the GAG chains, dissolv- 
ing in NCS tissue-homngenizing  solution (Amersbam Corp.) or TS-1 tissue 
solubilizer (Research Products International Corp., Mt. Prospect,  IL), and 
counting in a liquid scintillation  counter. 
To screen transfected clones of cells for the production of trypsinogen 
or Ig ~ light chain lff*-lO  5 cells were incubated for 5 h at 37°C in 15 % C02 
in DME I-I21 lacking methionine and cysteine and supplemented with 2% 
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[35S]label. The culture media and cell extracts were recovered and adjusted 
to a final concentration of 0.3 % SDS and NDET. Samples were precleared 
by incubation for 30 min at room temperature with 100 pl of  prewashed SAC 
(Pansorbin or Zysorbin). The material that nonspeeitically bound to the 
SAC was removed by centrifugation and the samples were incubated for 16 h 
at 4°C with specific antiserum, either rabbit anti-mouse ~ or rabbit anti- 
rat trypsinogen. The amounts and types of antiserum to be used for im- 
munoprecipitations were optimized  using derivatives of  the mouse myeloma 
MPC-11  expressing K  light chain and transfected wild type AtT-20 cells ex- 
pressing trypsinogen (Baumal et al., 1973; Burgess et al., 1987).  Soluble 
immunoprecipitates were recovered by incubating with fixed SAC for 30 
min at room temperature. The preparation of samples for analysis by SDS- 
PAGE and autoradiography were as described (Burgess et al.,  1985). 
To examine the secreted proteins in the medium after stimulation with 
the  secretagogue,  8-Br-cAMP,  106-107  cells  were treated  as described 
(Burgess et al., 1985, 1987). Trypsinogen-expressing  wild type AtT-20 ceils 
or variant HYA.15.6.T.3 cells were incubated first for 16 h in depleted DME 
containing 200 #Ci lzSS]cysteine,  10% FCS, glutamine, penicillin, strep- 
tomycin, and l/5th volume complete medium, and then for a  1-h interval 
in fresh labeling medium containing [3sS]cysteine at the same specific ac- 
tivity.  After the labeling period, cells were washed twice with PBS and 
chased in normal media for three 2.5-h intervals. During the third interval 
one portion of ceils was incubated in the presence of 5 mM 8-Br-cAMP to 
stimulate release from the regulated secretory pathway. The media and cell 
extracts were collected at each time interval and immunoprecipitated with 
rabbit anti-trypsinogen, anti-proinsniin or anti-kappa antiserum as de- 
scribed. Immunoprecipitates were analyzed on SDS-PAGE gels and the 
amount of  rnaterial that was secreted was quantified by cutting out the bands 
from the gels, fluting the labeled proteins in tissue-solubilizing solution at 
60°C for 16 h and counting in a liquid scintillation counter and by scanning 
the autoradiograph of the gel with a soft laser densitometer (LKB Instru- 
ments, Inc., Bromma, Sweden). Proinsulin secretion were examined by es- 
sentially the same procedure except that immunoprecipitates were washed 
in distilled water to remove detergent and analyzed on 12-20%  gradient 
SDS-PAGE gels. The identity of  the proinsulin and mature processed insulin 
bands were distinguished  on gels by molecular weight and by using two anti- 
serum, a rabbit anti-human C peptide (recognizes proinsniin only) and a 
guinea pig anti-mature insulin (recognizes both forms). ~ chain secretion 
by transfected ART20 cells was determined as described for trypsinogen ex- 
cept that 100 t~Ci [35S]methionine  was used for the labeling and cells were 
chased for two 3-h intervals, the latter interval in the presence or absence 
of 8-Br-cAMP. The amounts of the endogenous hormone, ACTH, that were 
released into the media during the stimulation interval was determined by 
a solid-phase ACTH radioimmunoassay that has been previously described 
(Moore et al., 1983b).  Protein determinations were assayed by an Amido 
Schwartz dye-binding assay (Moore et al.,  1983b). 
Synaptophysin was detected by immunoprecipitation of cell extracts la- 
beled for 16 h with Trans [35S]label with either a rabbit anti-rat synaptic 
vesicle antiserum (Cutler and Cramer, 1990) that recognized synaptophysin 
or with preimmune serum, followed by SAC. 
Immunofluorescence and EM 
Anti-ACTH immunofluorescence was performed as described (Matsuuchi 
et al.,  1988).  Cells were grown on poly-D-lysine-coated glass coverslips, 
incubated with rabbit anti-ACTH antibodies and sheep anti-rabbit IgG cou- 
pled to fluorescein (Cappel Laboratories, Cochranville, PA).  Antisynap- 
tophysin (p38) immunofluorescence was done on fixed and 0.01% Triton 
X-100 permeabilized cells with the monoclonal antibody, SY38 (Boehringer 
Mannheim Biochemicals) diluted 1:2, followed by fluorescein-coupled  goat 
anti-mouse ~/1 (diluted 1:10) as described (Matsunchi et al., 1988). EM was 
performed as described (Matsuuchi et al.,  1988). 
Results 
ART-20 Variants  Lacking ACTH 
In an attempt to generate antibody-secreting endocrine cells, 
the mouse pituitary cell line AtT-20, which is ouabain sensi- 
tive and HAT resistant, was fused to the mouse plasmacy- 
toma, 4TOO1, which is ouabain resistant and HAT sensitive. 
Clones were selected that survived several rounds of selec- 
tion in medium containing ouabain (2.5 mM) and HAT. The 
surviving clones differed from wild type cells in that they 
grew slowly and extended thin branching processes several 
cell bodies in length. Individual subclones were tested by im- 
munofluorescence, after fixation and detergent permeabili- 
zation of cells, for the expression of the endogenous hor- 
mone  expressed  by  AtT-20  cells,  ACTH.  Metabolically 
labeled clones were also tested by immunoprecipitation for 
expression of the antibody produced by the plasmacytoma, 
IgG2b, x.  Of 33  subclones that were recovered,  none ex- 
pressed antibodies, 30 expressed ACTH, two were mixed, 
containing both ACTH expressing and nonexpressing ceils, 
and one appeared to be an ACTH nonexpressor. None of the 
subclones retained the ouabain resistance of the myeloma 
parent. 
The ACTH nonexpressor was subcloned two additional 
times to ensure that no cells in the culture were express- 
ing ACTH (HYA.15.6),  then further characterized. Sibling 
clones of cells that expressed ACTH were also isolated dur- 
ing the subcloning of HY.15.6 for use as ATCH-expressing 
control  cells  (HYA.15.10).  AtT-20  cells  normally extend 
processes when plated on glass or plastic substrates.  This 
process  can  be  enhanced by  incubating  cells  in  growth 
medium containing 5 mM 8-Br-cAMP (Burgess and Kelly, 
1985).  When HYA.15.6 or HYA.15.10 cells were plated on 
glass  coverslips,  however,  they both  extended long,  thin 
processes without stimulation with the secretagogue, 8-Br- 
cAMP. ACTH could be detected by immunofluorescence in 
HYA.15.10 cells but not in HYA.15.6 cells (Fig. 1). A sensi- 
tive radioimmunoassay was used to detect ACTH in cell ex- 
tracts. Wild type AtT-20 cells contained 29.9 ng ACTH/#g 
cell protein, HYA.15.10 cells contained 1.4 ng ACTH/#g cell 
protein,  and HYA.15.6  ceils contained less than 0.10  ng 
ACTH/#g cell protein (the limit of detection of this assay), 
at least 300-fold less than wild type cells. 
Absence of the Regulated Pathway  in the 
AtT-20 Variant 
In normal AtT-20 cells, ACTH is condensed and packaged 
into secretory granules,  which have electron-dense cores 
when observed in electron micrographs. To see if dense core 
secretory granules were present or absent in the HYA.15.6 
variant cells, sections of epon-embedded cells were exam- 
ined in the electron microscope.  Electron micrographs of 
25  random fields of ACTH-negative HYA.15.6 or ACTH- 
positive HYA.15.10  cells were taken and the numbers of 
dense core granules counted. Photos of ACTH-positive cells 
(HYA.15.10)  contained  681  morphologically  identifiable 
dense  core  vesicles.  In  contrast,  photos  of the  ACTH- 
negative cells (HYA.15.6),  contained only one dense struc- 
ture that could have been a dense core vesicle. 
If the variant line had lost the regulated pathway, it should 
not be able to store, and secrete on stimulation the other 
soluble components of dense core secretory granules. These 
include chromogranin A (Iacangelo et al.,  1988),  secreto- 
granins (Rosa et ai.,  1985),  sulfated proteins such as B15 
(Moore et al., 1983a), and the "sulfated staircase" which rep- 
resent proteoglycans that are sulfated on glycosaminoglycan 
(GAG) side chains (Moore et al., 1983a; Burgess and Kelly, 
1984). Many of these components were not expressed by the 
HYA.15.6 variant. The sulfated proteoglycans and proteins, 
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acrylamide gels of intracellu- 
lar and secreted [35S]sulfated 
macromolecules  and  GAG 
chains from control and vari- 
ant  AtT-20 cells.  (A)  Cells 
were labeled with [~SS]sulfate, 
chased, and stimulated to se- 
crete with 5 mM 8-Br-cAMP 
as described in Materials and 
Methods. (Lanes 1, 3, 5, and 
7) without stimulation; (Lanes 
2,  4,  6,  and  8)  with  cAMP 
stimulation;  (Lanes  1  and 
2)  secreted  material  from 
HYA.15.10; (Lanes  3 and 4) se- 
creted material  from HYA.15.6; 
(Lanes 5  and  6)  HYA.15.10 
cell extracts; (Lanes 7 and 8) 
HYA.15.6 cell  extracts. (B) 
Cells were labeled with [35S]- 
sulfate  in  the  presence  of 
0.5 mM 4-methylumbelliferyl 
/5-D-xyloside. (Lane 1) GAG 
chains  secreted  from  wild 
type  AtT-20 cells.  (Lane  2) 
GAG  chains  secreted  from 
HYA.15.6 cells. 
sorted into the regulated secretory pathway and released on 
stimulation of cells containing the regulated secretory path- 
way, HYA.15.10 (Fig. 2 A, lanes I  and 2), were not made or 
released into the medium by the HYA.15.6 variant (Fig. 2 A, 
lanes  3  and  4).  The only sulfated material  in  extracts of 
HYA.15.6  cells was higher molecular weight material that 
did not enter the gel and some material that migrated as a 
diffuse band (Fig. 2 A, lanes 7 and 8). Although some sul- 
fated material migrating at 97 kD could be seen decreasing 
in the cell extracts after stimulation, a corresponding appear- 
ance in the stimulated medium could never be reproducibly 
detected. In addition, neither chromogranin A nor its mRNA 
could be easily detected in HYA.15.6  cells because expres- 
sion was at such low levels (Grimes, M., and R. B. Kelly, 
unpublished results). 
Although  the  dense  core vesicle-specific proteoglycans 
and other sulfated molecules were absent in the HYA.15.6 
variant cells, the machinery to synthesize the glycosamino- 
glycan side chains of  proteoglycans was still intact. This was 
shown by preincubating cells in medium containing 0.5 mM 
4-methyl-umbelliferyl xyloside and  labeling  cells,  in  the 
continued presence of xyloside, with [35S]sulfate. Xylosides 
compete with the protein core of proteoglycans for attach- 
ment of free GAG chains.  The 35S-labeled free GAG chain 
xyloside conjugates in cell extracts and media were recov- 
ered and analyzed on SDS-polyacrylamide gels. Wild type 
ART-20 cells, grown in the xyloside analogue, secreted into 
the medium a ladder of GAG chains, migrating between the 
protein molecular weight markers of 2 and 18 kD (Fig. 2 B, 
lane/). The HYA.15.6 variant cells, grown under the same 
conditions, secreted a ladder of sulfated GAG chains of rough- 
ly the same molecular weight although the ladder was less 
discrete (Fig. 2 B, lane 2). 
To test the possibility that secretory granules were present 
in the variant, but lacked identifiable markers, the storage 
and release of free GAG chains were used as a nonspecific 
granule content marker. In earlier work, 3~S-sulfated GAG 
chains appeared to segregate as a bulk phase marker into 
both regulated and constitutive pathways (Burgess and Kelly, 
1984). To measure GAG storage and release from the regu- 
Figure 1. Indirect immunofluorescence  and phase images of  control and variant Aft-20 cells. Cells were permeabilized and stained for ACTH 
(a and c) or observed by phase microscopy (b and d). HYA.15.10 (a and b); HYAA5.6 (c and d). Bar, 200 ~m. 
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Figure 3. Kinetics of secretion 
of  free GAG chains from wild- 
type and variant AtT-20 cells. 
(  A and B ) Wild type AtT-  20 (  A ) 
and variant HYA.15.6 (B) cells 
were labeled for 1 h with [35S]- 
sulfate and chased for 15, 30, 
45, 60, 90,  120, 150, or 210 
min.  Secreted (e,&) and in- 
traceUular (o,zx) GAG chains 
were  recovered  from  SDS- 
polyacrylamide by dissolving 
the  gel  in  tissue  solubilizer 
and quantified by liquid scin- 
tiUation counting. (C and D) 
Wild type AtT-20  (C) and vari- 
ant HYA.15.6 (D) ceils, pulsed 
and chased as described in A 
and B, were taken at 60 or 150 
min of chase and either stimu- 
lated to secrete GAG chains 
with 5 mM 8-Br-cAMP  or not. 
GAG chains  in  the  secreted 
media were recovered at ei- 
ther 150 rain of chase (for the 
60-min  addition)  or  at  210 
rain of chase (for the 150-min 
addition). (n) Without cAMP; 
([]) with cAMP. 
lated pathway, wild type AtT-20 ceils were labeled with a 1-h- 
pulse of [35S]sulfate and chased for varying lengths of time. 
The [35S]GAGs were identified after gel electrophoresis as 
the ladder of radioactive material that migrated between the 
protein molecular weights of 2.3-14 kD (Fig. 2 B). In wild 
type cells,  40%  of the  [3sS]GAGs were secreted into the 
medium with a half time of ,x,30 min, while the remainder 
of the GAGs was stored intracellularly (Fig.  3 A). After a 
chase  period,  treatment  with  8-Br-cAMP  increased  the 
amount of GAG chains released into the media twofold, sug- 
gesting that GAGs were indeed stored in the regulated secre- 
tory pathway (Fig. 3 C).  In contrast, variant cells released 
98 % of their [35S]GAG  chains, with a halftime also of •  30 
min (Fig. 3 B). No stimulation of secretion of the remaining 
2 % of the GAG chains could be seen after the addition of 
8-Br-cAMP (Fig. 3 D). Longer incubation times of cells in 
xyloside  and  [35S]sulfate more  extensively  labeled  the 
stored pools of [35S]GAG chains  in wild type cells,  since 
they have a half-time longer than 1 hour. No evidence of stor- 
age of GAG chains or their regulated release could be de- 
tected in the variant cells even under these conditions. Wild 
type AtT-20 cells were over twenty times more efficient at 
storing  [35S]GAGs than  the  variant  and  the  GAGs  were 
stored as efficiently as trypsinogen, ACTH, and insulin. Ei- 
ther the variant did not have secretory granules into which 
GAGs may flow, or the GAGs could not enter the granules 
because of missing components of the sorting machinery. 
The apparent efficiency  of sorting of the GAG chains into the 
regulated pathway is not consistent with the earlier assump- 
tion (Burgess and Kelly, 1984) that they can be used as a bulk 
phase marker. 
Expression of a Regulated Secretory Protein 
in Variant Cells 
If empty secretory granule membranes were present in the 
variant cells, and absence of the dense core was because of 
the lack of specific contents (as opposed to free GAG chains) 
to be packaged in the membranes, then secretory granules 
might be induced in the variant by introducing a protein nor- 
maily packaged into vesicles of  the regulated pathway. To test 
this possibility,  trypsinogen,  a  protein that is  sorted into 
regulated granules was expressed in HYA.15.6 variant cells 
by DNA-mediated transfection. Trypsinogen is targeted in 
transfected wild type cells to the same regulated secretory 
compartment that houses the endocrine hormones, ACTH, 
and insulin (Burgess et al.,  1985,  1987; Orci et al.,  1987). 
To test for the formation of a regulated pathway in trypsino- 
gen transfected AtT-20 variants, cells were labeled for 16-20 h 
in medium containing  [35S]methionine  or cysteine, chased 
for several intervals, and then stimulated to release the la- 
beled material in the regulated pathway (Moore and Kelly, 
1985;  Burgess  et al.,  1985).  In agreement with previous 
reports, trypsinogen secretion from wild type cells was char- 
acteristic of the regulated secretory pathway (Burgess et al., 
1985; Moore et al., 1983b). There was a slow release of la- 
beled trypsinogen in the absence of stimulation. Only 13 % 
of the total labeled trypsinogen was released in the first chase 
period and the secretion rate fell off with a half time of 5 h. 
A  5.3-fold increase in release of trypsinogen was obtained 
when the secretagogue 8-Br-cAMP was present during the 
last chase period (Fig. 4 A). In contrast, trypsinogen secre- 
tion from the HYA.15.6.T.3  variant was much more rapid. 
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Figure 4. Kinetics of trypsinogen, proinsulin/insulin, 
and mouse immunoglobulin K secretion from either 
transfected wild-type AtT20 cells or from transfected 
variant HYA.15.6.T.3 cells.  Cells were labeled with 
['S]Met or [35SlCys for 18 h to approach  steady- 
state labeling conditions, Two (D) or three (A, B, and 
C)  consecutive 2.5-h  chases  were  done  after the 
labeling period (refers to numbers 1, 2, and 3 chase 
intervals),  with the last chase  interval done in the 
presence or absence of 5 mM 8-Br-cAMP. Secreted 
and intracellular proteins were recovered by immuno- 
precipitation.  (A) Trypsinogen secreted from trans- 
fected AtT-20 cells. (B) Trypsinogen secreted from 
transfected variant  HYA.15.6 cells.  (C)  Proinsulin 
([]) and mature insulin ([]) secreted from AtT-20  cells. 
(D) Mouse immunoglobulin K  chain (from the MPC- 
11 mouse myeloma tumor) secreted from AtT-20  cells. 
90% of the trypsinogen was released during the first chase 
interval, consistent with a half time of secretion of ~,,40 rain. 
The amount of trypsinogen that was  secreted was  not in- 
creased by exposure to 8-Br-cAMP (Fig. 4 B). Expression 
of the regulated secretory protein, trypsinogen, by the vari- 
ant cells does not, therefore, induce formation of the regu- 
lated  secretory pathway  or reveal the  presence of empty 
secretory granules, lacking content proteins. 
:The unstimulated release of trypsinogen by the variant, 
corresponding to a half time of secretion of *40 min,  is 
considerably faster than unstimulated release by wild type 
AtT-20 (t~ =  5 h). The rate of trypsinogen release from un- 
stimulated variant cells was compared to the rate of constitu- 
tive secretion of immunoglobulin chains by wild type cells. 
In plasma cells, secretion of antibodies has been shown to 
be Constitutive, with no evidence for their storage or their 
stimulated release (Tartakoff  and Vassalli, 1978; Tartakoff  et 
al.,i 1977). Antibodies are convenient constitutive secretory 
proteins to study because the genes for the immunoglobulin 
heavy and light chains expressed by many plasma cell tumor 
lines have been cloned. A cell line of particular interest, the 
MPC-11 plasmacytoma, expresses both IgG2b heavy chain 
and r  light chain but over-expresses the latter. The r  light 
chains not assembled with heavy chain are secreted freely 
into the medium (Laskov and Scharff, 1970), making r chain 
a good candidate for a simple, soluble product to use as a 
constitutive secretory marker in nonlymphoid cells such as 
AtT-20 cells. AtT-20 cells transfected with the MPC11 r light 
chain gene made high levels of r chain, and secreted it with 
kinetics that were identical to that of immunoglobulin secre- 
tion in normal plasma cell lines. In transfected cells, 75 % 
of the labeled r light chain was secreted during the first chase 
interval and the half time of secretion was '~1 h. Stimulation 
with 8-Br-cAMP did not enhance the amount of light chain 
secreted  (Fig.  4  D).  Since  transfected  trypsinogen  was 
secreted from the AtT-20 variant at a rate indistinguishable 
from that of the constitutively secreted r-light chain in trans- 
fected wild type cells (Fig. 4, B and D), it is very likely that 
unstimulated secretion in the variant is from the constitutive 
secretory pathway. 
If constitutive secretion of trypsinogen and r  chain has a 
half time of •1  h, as the data from the variant show, the slow 
unstimulated  release  of trypsinogen from wild type cells 
(Fig. 4 ,4) must have another explanation. One possibility is 
that unstimulated release in wild type cells is not due entirely 
to constitutive secretion but also because of basal release. 
Basal release is secretion from the regulated pathway in the 
absence  of prior  stimulation  with  a  secretagogue.  If  a 
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sorting into the regulated pathway (Orci et al., 1987b),  then 
basal release will appear as the unstimulated release of ma- 
ture hormone. When the secretion of insulin forms was ex- 
amined in wild type cells (Fig. 4 C), mature insulin was in- 
deed  released  in the  absence  of stimulation.  During  the 
chase,  the  rate  of [35S]labeled insulin  secretion dropped 
with a half life of,'o 3 h, while the rate of  proinsulin secretion 
fell with a half time of only 40 rain. The kinetics suggest that 
mature insulin is released basally from secretory granules 
and proinsulin  from the  constitutive pathway.  Consistent 
with this explanation is  the observation that whereas ex- 
posure to 8-Br-cAMP increased the rate of insulin secretion 
sevenfold, it had no effect on the rate of proinsulin secretion. 
Proinsulin-transfected HYA.15.6 variant cells secreted proin- 
sulin and neither stored it nor processed the prohormone to 
the mature form (data not shown). Comparison of the variant 
and wild type cells clearly demonstrates therefore, two forms 
of unstimulated release, constitutive and basal. 
Discussion 
In the initial experiments on pathways of secretory protein 
sorting in AtT-20 cells, the regulated pathway was function- 
ally defined by secretion of the ACTH hormone in response 
to a secretagogue while the constitutive pathway was defined 
by the externalization of a viral membrane protein, gp70, 
which did not require exposure to a secretagogue (Gumbiner 
and Kelly, 1982). Unresolved in this work and in subsequent 
studies was whether constitutive secretion accounted for all 
unstimulated release, especially the slow release observed 
for "regulated" proteins, endogenous as well as transfected 
(Burgess et al., 1985; Moore and Kelly, 1985).  The AtT-20 
variant was clearly lacking the regulated secretory pathway 
and all secretion from these cells was rapid and constitutive. 
The characteristics of secretion by the variant allow us to 
propose that there must be two pathways of unstimulated re- 
lease in wild type cells: constitutive secretion, as described 
in our earlier work, and basal release from compartments 
that come after sorting into the regulated pathway. Since the 
regulated pathway is missing from the variant, basal release 
must also be missing. Basal release may be because of the 
fusion  of mature  regulated  secretory  granules  with  the 
plasma membrane in the absence of stimulation or the bud- 
ding of vesicles from immature granules as proposed by yon 
Zastrow et al. (1987). Whatever the mechanism of basal re- 
lease, it accounts for a large fraction of  the total secreted pro- 
tein and has important consequences for the analysis of sort- 
ing in neuroendocrine cell lines. Thus measuring the ratio 
of stimulated to unstimulated release need not be a measure 
of sorting but a measure of what fraction of the material 
sorted into the regulated pathway that can be released by 
stimulation with secretagogues. Furthermore, the sorting in- 
dex used by Moore and Kelly (1985) to measure protein sort- 
ing efficiencies, by ignoring basal release, underestimates 
the ability of AtT-20 cells to correctly sort proteins into the 
regulated pathway. 
Basal release from endocrine tissue may be physiologi- 
cally relevant. If endocrine cells in an organism have a basal 
level of secretion then they can respond to both positive and 
negative stimuli, to raise or lower hormone levels in the 
blood. The presence of basal secretion in tumor cell lines is 
perhaps because of a property of normal cells rather than to 
an  aberration  in  the  control  of the  regulated  secretory 
process. 
Although the variant was recovered from a somatic cell hy- 
bridization between AtT-20 cells and mouse myeloma cells, 
it is unlikely to represent a true hybrid between AtT-20 cells 
and the myeloma cells since it lacks properties of the my- 
eloma parent, immunoglobulin expression, and resistance to 
oubain (Margulies et al., 1976). In contrast, the variant ex- 
hibited many properties of the AtT-20 parent. The ceils sur- 
vived  exposure to HAT medium, were adherent  with extended 
processes,  and  expressed  synaptophysin  (p38;  data  not 
shown) a membrane protein shared between neurons and en- 
docrine cells (Navone et al., 1986; John et al., 1985; Franke 
et al., 1986; Weideman and Franke, 1985). The variant also 
targeted the synaptophysin it made to synaptic vesicle-like 
structures  (data  not shown),  a  characteristic property  of 
neuroendocrine  cell  lines  (Clift-O'Grady  et  al.,  1990). 
HYA.15.10, a  subclone that retained the ability to express 
ACTH, also contained dense core secretory granules, and 
retained the ability to release material from the regulated 
pathway. The AtT-20 cells that survived drug selection may 
be spontaneous variants that were resistant to short exposure 
to ouabaln, perhaps because of their slow growth rate. 
The HYA.15.6 variant exhibited multiple defects, includ- 
ing the loss of secretory granules with an electron-dense 
core,  and  the  loss  of  several  granule  content  proteins, 
ACTH, sulfated proteins (B15), and granule-specific sulfated 
proteoglycans. The variant could reflect an early develop- 
mental state before the expression of the secretory granule 
content proteins is switched on, assuming that expression of 
granule contents is required for dense core secretory granule 
formation. We cannot determine whether, in the absence of 
dense core formation, empty secretory granule membranes 
still form, but if they do they are not capable of storing and 
releasing on stimulation the exocrine protein trypsinogen. 
Since the regulated pathway-deficient variant could not 
store free GAG chains, this storage property (and release of 
free GAG chains after stimulation) in wild type cells must 
be because of the regulated pathway.  In wild type AtT-20 
cells,  almost half of the  [35S]GAG chains made in a  1-h 
pulse, remained stored in a releasable compartment at the 
end of a long chase (Fig. 3).  The storage of GAGs in the 
regulated secretory pathway was of surprisingly high effi- 
ciency, comparable to that found for ACTH, human growth 
hormone (Moore and Kelly, 1985), trypsinogen (Burgess et 
al., 1985),  and insulin (Kelly et al., 1989). Apparently, the 
GAG chains are not true bulk-phase markers as proposed by 
Burgess and Kelly (1984).  A  tripeptide (N-octonoyI-ASN- 
TYR-THR-NH2) that behaves as a bulk-phase marker (Wie- 
land et al.,  1987) is excluded from the regulated secretory 
pathway in insulin-secreting cells (Gold et al., 1988). GAGs 
may be sorted from the trans-Golgi network into the secre- 
tory granules either by a GAG-specific receptor, similar to 
the hormone-specific receptor (Chung et al., 1989), or by as- 
sociation with a protein that is sorted. The latter mechanism 
has been invoked to explain sorting of  an anti-secretogranin I 
antibody into secretory granules (Rosa et al., 1989). An al- 
ternative possibility is that in AtT-20 cells the machinery for 
synthesizing and sulfating GAG chains remain active in the 
immature granule after protein sorting events have occurred. 
Consistent with this alternative in our finding in AtT-20 cells 
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be sorted more efficiently than methionine or cysteine-labeled 
proteins (Matsuuchi,  L.,  and R.  B.  Kelly, unpublished re- 
suits). Preferential secretion from parathyroid tissue of sul- 
fate-labeled chromogranin A is also seen and was explained 
by proposing that sulfation occurs after the sorting of chro- 
mogranin  into secretory granules  (Gorr and Cohn,  1990). 
In pulse-labeled PC12 cells, in contrast, no sulfation of im- 
mature or mature secretory granules  was seen (Tooze and 
Huttner,  1990).  To resolve this point,  similar experiments 
need to be done in wild type and variant AtT-20 cells. 
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